Analytical aspects of molecular Alzheimer’s disease biomarkers

Reference measurement procedures for Alzheimer’s disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42

(2012) Niklas Mattsson et al.   Biomarkers in Medicine

Cerebrospinal Fluid Collection Tubes: A Critical Issue for Alzheimer Disease Diagnosis

(2012) A. Perret-Liaudet et al.   CLINICAL CHEMISTRY

The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers

(2011) Niklas Mattsson et al.   Alzheimers & Dementia

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

(2011) Hugo Vanderstichele et al.   Alzheimers & Dementia

Quantitation of amyloid beta peptides Aβ1–38, Aβ1–40, and Aβ1–42 in human cerebrospinal fluid by ultra-performance liquid chromatography–tandem mass spectrometry

(2011) Mary E. Lame et al.   ANALYTICAL BIOCHEMISTRY

Analysis of Amyloid-β Peptides in Cerebrospinal Fluid Samples by Capillary Electrophoresis Coupled with LIF Detection

(2011) Romain Verpillot et al.   ANALYTICAL CHEMISTRY

New diagnostic criteria for Alzheimer’s disease

(2011) Henrik Zetterberg   Biomarkers in Medicine

Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden — Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials

(2011) Maria Isaac et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study

(2011) Jonathan H Williams et al.   Alzheimers Research & Therapy

Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications

(2011) Robert Laforce et al.   Alzheimers Research & Therapy

Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

(2010) William T. Hu et al.   ACTA NEUROPATHOLOGICA

Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression

(2010) Pascale Fehlbaum-Beurdeley et al.   Alzheimers & Dementia

Electrogenerated Chemiluminescence

(2010) Robert J. Forster et al.   Annual Review of Analytical Chemistry

A Serum Protein–Based Algorithm for the Detection of Alzheimer Disease

(2010) Sid E. O’Bryant   ARCHIVES OF NEUROLOGY

The clinical use of structural MRI in Alzheimer disease

(2010) Giovanni B. Frisoni et al.   Nature Reviews Neurology

Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process

(2010) Bart De Strooper   PHYSIOLOGICAL REVIEWS

AlphaLISA Immunoassay Platform— The “No-Wash” High-Throughput Alternative to ELISA

(2009) Martina Bielefeld-Sevigny   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease

(2009) C. Mulder et al.   CLINICAL CHEMISTRY

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Characterization of Tau in Cerebrospinal Fluid Using Mass Spectrometry

(2008) Erik Portelius et al.   JOURNAL OF PROTEOME RESEARCH